Page last updated: 2024-10-27

gabapentin and Dysgeusia

gabapentin has been researched along with Dysgeusia in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.

Research Excerpts

ExcerptRelevanceReference
" We report here the first use of gabapentin in two glioblastoma patients who developed dysgeusia following intra-arterial administration of carboplatin or oral administration of lomustine, respectively."7.96Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin. ( Fortin, D; Iorio-Morin, C; Touchette, CJ; Turcotte, K, 2020)
" We report here the first use of gabapentin in two glioblastoma patients who developed dysgeusia following intra-arterial administration of carboplatin or oral administration of lomustine, respectively."3.96Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin. ( Fortin, D; Iorio-Morin, C; Touchette, CJ; Turcotte, K, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Turcotte, K1
Touchette, CJ1
Iorio-Morin, C1
Fortin, D1

Other Studies

1 other study available for gabapentin and Dysgeusia

ArticleYear
Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:6

    Topics: Administration, Oral; Dysgeusia; Gabapentin; Glioblastoma; Humans; Quality of Life

2020